Robert J. Shovlin, President, Clinical Services at NEOGENOMICS INC (NEO), sold 372,028 shares at $18.88 ($7.1M) on 2019-02-26, disclosed to the SEC on 2019-02-28.
Open-market sale of $7.1M NEO by President, Clinical Services. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.88 | 141,879 | $2.7M | 38.0% |
| 2 | $18.88 | 141,879 | $2.7M | 38.0% |
| 3 | $19.23 | 44,135 | $849K | 12.0% |
| 4 | $19.23 | 44,135 | $849K | 12.0% |
| Total | $18.96 avg | 372,028 | $7.1M | 100% |
| Filing → |
| NEO | SELL | 2020-03-05 | $6.1M | — | Filing → |
| NEO | SELL | 2019-11-04 | $4.9M | — | Filing → |
| NEO | SELL | 2019-05-06 | $5.3M | — | Filing → |